Insider Transactions in Q4 2024 at Arcus Biosciences, Inc. (RCUS)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 31
2024
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,594
-5.64%
|
$53,910
$15.0 P/Share
|
|
Dec 19
2024
|
Alexander Azoy Chief Accounting Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
3,007
-18.68%
|
$45,105
$15.17 P/Share
|
|
Dec 15
2024
|
Juan C. Jaen President |
SELL
Payment of exercise price or tax liability
|
Direct |
17,286
-5.17%
|
$276,576
$16.08 P/Share
|
|
Dec 15
2024
|
Alexander Azoy Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,969
-15.57%
|
$47,504
$16.08 P/Share
|
|
Dec 15
2024
|
Ii Robert C. Goeltz Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,099
-13.68%
|
$161,584
$16.08 P/Share
|
|
Dec 15
2024
|
Dimitry Sa Nuyten Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,856
-8.24%
|
$125,696
$16.08 P/Share
|
|
Dec 15
2024
|
Terry J Rosen Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
37,882
-1.57%
|
$606,112
$16.08 P/Share
|
|
Dec 15
2024
|
Carolyn C. Tang General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
11,339
-10.13%
|
$181,424
$16.08 P/Share
|
|
Dec 15
2024
|
Jennifer Jarrett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,501
-14.41%
|
$440,016
$16.08 P/Share
|
|
Dec 02
2024
|
Alexander Azoy Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
201
-1.04%
|
$3,015
$15.32 P/Share
|